Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes

Merry ZC Ruan1, Vincenzo Cerullo1,2, Racel Cela1, Chris Clarke1, Evy Lundgren-Akerlund3, Michael A Barry4, Brendan HL Lee1
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
2Laboratory of Immunovirotherapy, Division of Pharmaceutical Biosciences and Center for Drug Research, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
3Xintela AB, Lund, Sweden
4Mayo Clinic, Division of Infectious Disease, Department of Medicine, Rochester, Minnesota, USA

Tài liệu tham khảo